Cargando…

Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients

Pneumocystis jirovecii pneumonia (PJP) is a potentially life-threatening infection that occurs in immunocompromised patients. The aim of this study was to evaluate risk factors for PJP in kidney transplantation recipients. We conducted a retrospective analysis of patient data from 500 consecutive ki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Su Hwan, Huh, Kyu Ha, Joo, Dong Jin, Kim, Myoung Soo, Kim, Soon Il, Lee, Juhan, Park, Moo Suk, Kim, Young Sam, Kim, Se Kyu, Chang, Joon, Kim, Yu Seun, Kim, Song Yee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431538/ https://www.ncbi.nlm.nih.gov/pubmed/28484270 http://dx.doi.org/10.1038/s41598-017-01818-w

Ejemplares similares

Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer
por: Lee, Eun Hye, et al.
Publicado: (2019)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Clinical impact of pneumothorax in patients with Pneumocystis jirovecii pneumonia and respiratory failure in an HIV-negative cohort
por: Choi, Ji Soo, et al.
Publicado: (2022)

Comparative Evaluation Between the RealStar Pneumocystis jirovecii PCR Kit and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR Kit for Detecting P. jirovecii in Non-HIV Immunocompromised Patients
por: Huh, Hee Jae, et al.
Publicado: (2019)

Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness
por: Kim, Tae-Ok, et al.
Publicado: (2021)

Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure
por: Choi, Ji Soo, et al.
Publicado: (2018)

Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2019)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome
por: Kim, Ji Eun, et al.
Publicado: (2019)

Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group
por: Song, Young Hae, et al.
Publicado: (2012)

1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019)

The feasibility of organ transplantation during the COVID-19 outbreak: experiences from South Korea
por: Lee, Juhan, et al.
Publicado: (2020)

Clinical impact of serum bilirubin levels on kidney transplant outcomes
por: Lee, Juhan, et al.
Publicado: (2021)

Long-term compensation of renal function after donor nephrectomy
por: Lee, Yong Pyo, et al.
Publicado: (2020)

401. Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients After a 6-Month Trimethoprim–Sulfamethoxazole Prophylaxis: A Case–Control Study
por: Park, Se Yoon, et al.
Publicado: (2018)

Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk
por: Kim, Eun Jin, et al.
Publicado: (2021)

Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia
por: Cho, Ju-Yeon, et al.
Publicado: (2009)

Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea
por: Kim, Tark, et al.
Publicado: (2015)

Atypical Presentation of Pneumocystis jirovecii Infection in HIV Infected Patients: Three Different Manifestations
por: Kim, Bongyoung, et al.
Publicado: (2018)

Graft-versus-host disease after simultaneous pancreas-kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2020)

Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2018)

Rituximab protects against development of atherosclerotic cardiovascular disease after kidney transplantation: a propensity-matched study
por: Kim, Deok Gie, et al.
Publicado: (2019)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Spontaneous Pneumomediastinum, Pneumopericardium, and Pneumothorax with Respiratory Failure in a Patient with AIDS and Pneumocystis jirovecii Pneumonia
por: Park, Yun Kyung, et al.
Publicado: (2014)

Co-infection of Pneumocystis jirovecii and Aspergillus in a patient with idiopathic thrombocytopenic purpura
por: Lee, Dong-Hwa, et al.
Publicado: (2019)

Spelling Pneumocystis jirovecii
por: Stringer, James R., et al.
Publicado: (2009)

Etymologia: Pneumocystis jirovecii
por: Henry, Ronnie
Publicado: (2017)

Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study
por: Lee, Gongmyung, et al.
Publicado: (2022)

Late-Onset Granulomatous Pneumocystis jirovecii Pneumonia in A Renal Transplant Recipient: A Clinical Grand Round Conference Case in 2022
por: Baek, Yae Jee, et al.
Publicado: (2023)

Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR
por: Huang, Yuan, et al.
Publicado: (2023)

No Change of Pneumocystis jirovecii Pneumonia after the COVID-19 Pandemic: Multicenter Time-Series Analyses
por: Kim, Dayeong, et al.
Publicado: (2021)

Single Nodular Opacity of Granulomatous Pneumocystis Jirovecii Pneumonia in an Asymptomatic Lymphoma Patient
por: Kim, Hyun Soo, et al.
Publicado: (2015)

Clinical Characteristics and Treatment Outcomes of Colorectal Cancer in Renal Transplant Recipients in Korea
por: Kim, Jeong Yeon, et al.
Publicado: (2011)

Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients
por: Ling, Jonathan, et al.
Publicado: (2017)

Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients—preliminary report
por: Szydłowicz, Magdalena, et al.
Publicado: (2018)

Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis
por: Andreasen, Philip B., et al.
Publicado: (2021)

Assessment of cytomegalovirus and cell-mediated immunity for predicting outcomes in non-HIV-infected patients with Pneumocystis jirovecii pneumonia
por: Kim, Taeeun, et al.
Publicado: (2017)

Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells
por: Kim, Eun Jee, et al.
Publicado: (2021)

Pneumocystis jirovecii Pneumonia in Patients with Solid Malignancies: A Retrospective Study in Two Hospitals
por: Jeon, Cheon-Hoo, et al.
Publicado: (2022)

Antibody Response to Pneumocystis jirovecii: Antibody Response to Pneumocystis jirovecii Major Surface Glycoprotein
por: Daly, Kieran R., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_t8dovdtrhqhg8jtbr6coi94681